Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Tab. terbinafine 250 mg?

See the DrugPatentWatch profile for terbinafine

Terbinafine (250 mg tablet) – a common antifungal medication used to treat various superficial fungal infections. Below is a concise overview that covers the essentials you might need to know.

---

1. What Is Terbinafine?


- Drug Class: Allylamine antifungal
- Common Brand Names: Lamisil, Lamisil T, Lamisil 250 mg (generic)
- Form: Oral tablet (250 mg), topical creams, gels, and solutions are also available.

---

2. Approved Uses (Oral 250 mg)


| Infection | Typical Course (Adults) | Typical Course (Children) |
|-----------|------------------------|---------------------------|
| Onychomycosis (fungal nail infection) | 6–12 weeks (often 12 weeks for toenails, 6 weeks for fingernails) | 12 weeks (same dosing) |
| Tinea corporis/versicolor (skin infections) | 2–4 weeks | 2–4 weeks |
| Tinea pedis (athlete’s foot) | 2–4 weeks | 2–4 weeks |
| Tinea cruris (jock itch) | 2–4 weeks | 2–4 weeks |

Note: Dosing for children is typically based on body weight (usually 250 mg daily until a maximum of 1 mg/kg/day, not exceeding the adult dose). Always follow a clinician’s prescription.

---

3. How Does It Work?


Terbinafine inhibits squalene epoxidase, an enzyme essential for ergosterol synthesis in fungal cell membranes. This disrupts the fungal cell wall, leading to fungal cell death, especially in dermatophytes (tinea infections) and some yeasts.

---

4. Administration Tips


- Take with food (preferably a high‑fat meal) to enhance absorption.
- Avoid alcohol while taking terbinafine; it can increase the risk of liver toxicity.
- Stay consistent: Missed doses can reduce efficacy.

---

5. Common Side Effects


| Symptom | Frequency | What to do |
|---------|-----------|------------|
| Nausea, stomach upset | Mild‑moderate | Take with food, stay hydrated |
| Headache | Mild | OTC pain relievers (e.g., acetaminophen) |
| Diarrhea | Rare | Monitor stool, contact provider if persistent |
| Taste disturbances (altered taste) | Mild | Usually resolves after therapy |
| Liver enzyme elevations | Rare but serious | Routine liver function tests (LFTs) during treatment |

---

6. Serious but Rare Risks


- Liver toxicity – symptoms: yellowing of skin/eyes, dark urine, severe fatigue, upper abdominal pain. If you notice any of these, seek medical attention immediately.
- Photosensitivity – increased sun sensitivity; use sunscreen or protective clothing.
- Allergic reactions – rash, itching, swelling, especially of lips or face; severe reactions may need urgent care.

---

7. Drug Interactions


| Drug | Interaction | What It Means |
|------|-------------|---------------|
| Statins (e.g., simvastatin, lovastatin) | ↑ risk of myopathy and rhabdomyolysis | Avoid or adjust dose |
| Ketoconazole, Itraconazole | ↑ terbinafine levels | Use with caution |
| Warfarin | ↑ INR, bleeding risk | Monitor INR closely |
| Erythromycin, Clarithromycin | ↑ liver enzyme activity | May increase terbinfine levels |
| Grapefruit juice | ↑ absorption (rare) | Limit consumption |

Always inform your pharmacist/doctor about all medications, supplements, and herbal products you’re taking.

---

8. Precautions & Contraindications


- Pregnancy: Category B (limited data). Use only if benefits outweigh risks.
- Breastfeeding: Not recommended; terbinafine is excreted into breast milk.
- Liver disease: Contraindicated; liver enzymes must be normal before starting.
- Renal impairment: Dose adjustment not typically required, but monitor in severe CKD.
- Severe allergic reactions: Contraindicated.

---

9. Monitoring


- Baseline LFTs (ALT, AST, bilirubin) before starting therapy.
- Periodic LFTs: Every 2–3 weeks during prolonged treatment (≥4 weeks).
- Clinical review: Check for symptom improvement at 2–4 weeks, then every 4 weeks.

---

10. What If You Miss a Dose?


- If you miss a dose within 12 hours, take it as soon as you remember.
- If >12 hours have passed, skip the missed dose and resume the regular schedule.
- Never double up to make up for a missed dose.

---

11. Quick FAQ


- “Will it cure my nail infection in one week?”
No – onychomycosis usually requires 6–12 weeks for complete cure.

- “Can I use it topically for a fungal infection?”
Yes, topical terbinafine is effective for skin infections but not for nails.

- “Can I take it with my daily multivitamin?”
Generally safe, but taking it on an empty stomach may reduce absorption.

- “Is it safe to drive after taking it?”
No known CNS side effects, so driving is usually safe, but always check with your provider if you feel unwell.

---

12. Bottom Line


Terbinafine 250 mg tablets are a first‑line, effective treatment for many superficial fungal infections, especially onychomycosis. When taken as prescribed, most people experience good relief with minimal side effects. Keep an eye on liver function tests if you’re on a prolonged course, avoid alcohol, and let your healthcare provider know about any other medications or health conditions that might interact.

If you have any specific concerns—such as dosing in children, interactions with a particular drug, or what to do if you suspect liver trouble—feel free to ask!



Other Questions About Terbinafine :

Terbinafine tablet 250 mg? Terbinafine hydrochloride api?

AI-Drug Label Prescribing Information Alignment Report

32
32%
Grade D

Poor

Major Misalignment

Patient Risk: Medium

Summary

Multiple label-supported items were included (indication of onychomycosis; tablet strength/route; hepatotoxicity symptoms; serious skin reactions; taste disturbance; Dosing durations). However, several clinically important label elements are missing or not sufficiently specified (contraindications such as chronic/active liver disease and allergy; boxed warnings not assessed; liver-function test/monitoring requirement; detailed missed-dose rule). Some claims are unsupported or too general compared with the provided label text.


Category Scores

Indication
85
Good
Dosage
45
Partial
Contraindications
25
Poor
Warnings
55
Partial
AdverseReactions
60
Partial

Accurate Statements

Tab terbinafine 250 mg is terbinafine tablets.
3 DOSAGE FORMS AND STRENGTHS (tablet 250 mg) shows terbinafine tablets exist in 250 mg strength.
Terbinafine 250 mg is used to treat certain fungal infections.
1 INDICATIONS AND USAGE indicates terbinafine tablets are indicated for treatment of onychomycosis due to dermatophytes.
Terbinafine 250 mg is commonly used to treat skin fungal infections.
Not supported by provided label text (label provided only onychomycosis). Included here only as partially aligned to fungal infection treatment; see unsupported/omission.
For tablets labeled 250 mg, dosing is typically taken by mouth once daily.
2 DOSAGE AND ADMINISTRATION specifies 'One 250 mg tablet once daily' and label refers to oral terbinafine in multiple warnings (e.g., discontinue taking oral terbinafine).
The correct duration of terbinafine depends on infection type and severity.
2 DOSAGE AND ADMINISTRATION provides different durations for fingernail (6 weeks) vs toenail (12 weeks) and notes optimal effect relates to outgrowth period.
Skin fungal infections often need shorter courses of terbinafine.
Not supported as stated (label distinguishes fingernail vs toenail, not skin). This is included as a duration comparison that roughly matches 'fingernail shorter than toenail' but is mismatched to 'skin' (see contradictions/unsupported).
Toenail fungus usually takes longer with terbinafine because improvement depends on nail growth.
2 DOSAGE AND ADMINISTRATION: 'Toenail onychomycosis: ... 12 weeks' and 'outgrowth of healthy nail' and 'optimal clinical effect... months after mycological cure'.
Terbinafine can cause symptoms that could indicate a serious reaction such as widespread rash, swelling, or breathing trouble.
17 PATIENT COUNSELING: immediate report for hives, mouth sores, blistering/peeling skin, swelling of face/lips/tongue/throat, difficulty swallowing or breathing; discontinue treatment.
Terbinafine can cause signs of liver problems such as yellowing of the skin or eyes.
5.1 hepatotoxicity: report symptoms including jaundice.
Terbinafine can cause signs of liver problems such as dark urine.
5.1 hepatotoxicity: report symptoms including dark urine.
Terbinafine can cause signs of liver problems such as severe persistent nausea.
5.1: report symptoms including persistent nausea.
Terbinafine can cause signs of liver problems such as severe persistent nausea.
5.1 explicitly lists 'persistent nausea' as a symptom warranting discontinuation and evaluation.
People may need extra caution with terbinafine if they have liver disease.
2.1: 'evaluate patients for evidence of chronic or active liver disease'; 4 contraindications list chronic or active liver disease.
Terbinafine can cause signs of serious skin/hypersensitivity reactions such as rash.
5.6: reports of serious skin/hypersensitivity reactions and manifestations may include rash.
Terbinafine can cause taste changes.
5.2 Taste Disturbance Including Loss of Taste: taste disturbance including taste loss.
The optimal clinical effect is seen some months after mycological cure and cessation of treatment (nail outgrowth).
2.2 Dosage: 'optimal clinical effect is seen some months after mycological cure and cessation of treatment... outgrowth of healthy nail.'

Unsupported Statements

Terbinafine 250 mg is commonly used to treat skin fungal infections.
Provided label section 1 indicates onychomycosis of toenail or fingernail due to dermatophytes; no skin fungal infection indication is stated in the supplied label.
Common side effects of terbinafine can include stomach upset.
The label text provided includes hepatotoxicity symptoms (nausea, vomiting) as warning symptoms, but does not list 'stomach upset' as a common side effect in the provided sections.
Common side effects of terbinafine can include headache.
Headache is not mentioned in the provided label excerpts.
Common side effects of terbinafine can include rash.
5.6 describes serious skin/hypersensitivity reactions and postmarketing serious rash manifestations, but 'common side effects' is not supported by provided label text.
People may need extra caution with terbinafine if they have a history of significant drug reactions.
Provided label contraindicates history of allergic reaction to oral terbinafine due to risk of anaphylaxis; 'extra caution' phrasing for 'history of significant drug reactions' is not specifically supported.
People may need extra caution with terbinafine if they have significant medication interactions.
The label describes drug-drug interactions and advises careful monitoring and possible dose reduction for CYP2D6-metabolized drugs, but does not use 'extra caution if significant medication interactions' phrasing.
Terbinafine can interact with some medicines.
Drug interactions are described, but the claim is overly general and not tied to specific label-described interactions; still, some interaction content is present (see omissions/drugInteractions not scored).
Skin symptoms may improve within days to weeks with terbinafine.
The label excerpts discuss nail outgrowth and months after mycological cure; no 'skin symptoms within days to weeks' is supported by provided label.
Fungal infection is cleared over time with terbinafine.
The label provided supports clinical efficacy outcomes, but the claim is too general and not stated as 'cleared' in the provided label text; efficacy is described in trials for onychomycosis.
If a dose of terbinafine is missed, many regimens advise not doubling up without guidance.
No missed-dose instructions are provided in the supplied label excerpts. Patient counseling provides a specific rule for forgetting doses.

Contradictions

Low

AI Statement
Terbinafine 250 mg is commonly used to treat skin fungal infections.

Label Reference
1 INDICATIONS AND USAGE indicates indication for onychomycosis of toenail/fingernail due to dermatophytes; no skin fungal infection indication provided in supplied label text.

Low

AI Statement
Skin fungal infections often need shorter courses of terbinafine.

Label Reference
2 DOSAGE AND ADMINISTRATION provides durations by fingernail vs toenail onychomycosis, not skin infections.


Important Omissions

Contraindications: chronic or active liver disease; history of allergic reaction to oral terbinafine due to risk of anaphylaxis.
Importance: High
Requirement to obtain appropriate nail specimens (KOH, fungal culture, or nail biopsy) prior to initiating treatment.
Importance: Moderate
Specific dosing durations: fingernail onychomycosis 6 weeks; toenail onychomycosis 12 weeks.
Importance: High
Liver function test evaluation prior to prescribing and periodic monitoring of liver function tests; discontinue if biochemical/clinical evidence of liver injury develops.
Importance: High
Missed dose instruction: take as soon as remembered unless less than 4 hours before next dose is due (not provided as stated by AI).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Medium
The response includes some serious warning-related symptoms (liver injury; serious skin/hypersensitivity; taste disturbance) but omits major contraindications and key monitoring/evaluation instructions (liver function testing; contraindication in chronic/active liver disease; allergy contraindication). It also generalizes indications toward 'skin fungal infections' and does not provide label-specific dosing durations, increasing risk of mismatch to the labeled use and insufficient safety screening.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use Yes
Hallucination Risk Medium

Recommendation

Major Misalignment

Primary Issue
Unlabeled/incorrect indication framing toward 'skin fungal infections' plus omission of key contraindications and liver monitoring/evaluation instructions, and missing label-specific dosing durations and missed-dose rule.

Suggested Improvement
Align indication strictly to onychomycosis (toenail/fingernail due to dermatophytes) and include label-specific dosing (250 mg once daily for 6 weeks fingernails and 12 weeks toenails). Add contraindications (chronic/active liver disease; history of allergic reaction to oral terbinafine/anaphylaxis) and the label-required liver function testing/periodic monitoring and discontinuation criteria. Provide the exact missed-dose guidance from patient counseling: take when remembered unless less than 4 hours before next dose is due.

Drug Brand Mention Assessment

Branding Score
68
Visibility
63
Mentioned
Ranking
#1
Sentiment
60
Recommendation Status
mentioned only
Brand Perception
Best Known For

used to treat certain fungal infections


Core Claims
  • Tab terbinafine 250 mg is terbinafine tablets used to treat certain fungal infections
  • Dosing for 250 mg tablets is typically taken by mouth once daily for a defined course length
  • Treatment length depends on whether the infection is skin vs. nails
  • Common side effects can include stomach upset, headache, rash, or taste changes
  • People may need extra caution with liver disease, a history of significant drug reactions, or significant medication interactions
Differentiators
  • Treatment aims to clear fungal infection over time
  • Nail infections usually take longer because improvement depends on nail growth
  • Improvement timeline differs for skin vs. nails

Pricing Perception: Not Mentioned